SMTL ID : 6o0o.2 (1 other biounit)

crystal structure of BCL-2 G101V mutation with S55746

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x F3Q: ~{N}-(4-hydroxyphenyl)-3-[6-[[(3~{S})-3-(morpholin-4-ylmethyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]-1,3-benzodioxol-5-yl]-~{N}-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide(Non-covalent)

F3Q.1: 12 residues within 4Å: Chain A: F.63, Y.67, D.70, M.74, V.92, E.95, L.96, G.104, R.105, A.108, E.111, F.112 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Y.67, A:Y.67, A:D.70, A:V.92, A:V.92, A:L.96, A:L.96, A:A.108, A:F.112, A:F.112 Hydrogen bonds: A:Y.67 Salt bridges: A:D.70 pi-Stacking: A:F.63, A:F.63

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Birkinshaw, R.W. et al., Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations. Nat Commun (2019)

Release Date

2019-05-22

Peptides

Apoptosis regulator Bcl-2,Bcl-2-like protein 1,Apoptosis regulator Bcl-2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Apoptosis regulator Bcl-2,Bcl-2-like protein 1,Apoptosis regulator Bcl-2

Related Entries With Identical Sequence